AAOS Launches Strategic Biologics Initiative

Kerri Fitzgerald

In November 2019, AAOS announced the launch of its strategic investment in the field of biologics. Over the next five years, AAOS will prioritize research and development for a biologics-focused competency within the Academy’s existing member benefits, with a focus on creating evidence-based, unbiased information to help shape and guide orthopaedic surgeons who can then educate their patients on this topic.

Academy Defines Quality and Value in Musculoskeletal Health Care

Robert H. Quinn, MD, FAAOS; Jayson Murray, MA

When you think of “value-based health care,” what comes to mind? Is it all about cost? It’s far from breaking news that the United States leads the pack in health spending, with an average annual spend of 17.2 percent of gross domestic product (GDP).